Atara Biotherapeutics Inc
NASDAQ:ATRA

Watchlist Manager
Atara Biotherapeutics Inc Logo
Atara Biotherapeutics Inc
NASDAQ:ATRA
Watchlist
Price: 9.12 USD -1.46%
Market Cap: 61m USD

Wall Street
Price Targets

ATRA Price Targets Summary
Atara Biotherapeutics Inc

Wall Street analysts forecast ATRA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATRA is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 18.9 USD.

Lowest
Price Target
11.11 USD
22% Upside
Average
Price Target
15.64 USD
71% Upside
Highest
Price Target
18.9 USD
107% Upside
Atara Biotherapeutics Inc Competitors:
Price Targets
BRNS
Barinthus Biotherapeutics PLC
359% Upside
300676
BGI Genomics Co Ltd
2% Upside
BEAM
Beam Therapeutics Inc
146% Upside
688382
InventisBio Co Ltd
18% Downside
ELUT
Elutia Inc
284% Upside
PBYI
Puma Biotechnology Inc
21% Upside
1952
Everest Medicines Ltd
1% Downside
ONCO
Oncopeptides AB
279% Upside

Revenue
Forecast

Revenue Estimate
Atara Biotherapeutics Inc

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is -43%.

N/A
Past Growth
-43%
Estimated Growth
Estimates Accuracy
-41%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
4%
Average Beat

Net Income
Forecast

Net Income Estimate
Atara Biotherapeutics Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-70%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATRA's stock price target?
Price Target
15.64 USD

According to Wall Street analysts, the average 1-year price target for ATRA is 15.64 USD with a low forecast of 11.11 USD and a high forecast of 18.9 USD.

What is Atara Biotherapeutics Inc's Revenue forecast?
Projected CAGR
-43%

The compound annual growth rate of Atara Biotherapeutics Inc's revenue for the next 3 years is -43%.

Back to Top